These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 31579679)

  • 1. Subjective swallowing symptoms and related risk factors in COPD.
    Gonzalez Lindh M; Malinovschi A; Brandén E; Janson C; Ställberg B; Bröms K; Blom Johansson M; Lisspers K; Koyi H
    ERJ Open Res; 2019 Jul; 5(3):. PubMed ID: 31579679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Swallowing dysfunction in patients hospitalised due to a COPD exacerbation.
    Gonzalez Lindh M; Janson C; Blom Johansson M; Jonsson M; Mälberg E; Allansson E; Holm C; Jennische M; Koyi H
    ERJ Open Res; 2021 Apr; 7(2):. PubMed ID: 34109239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of Health-Related Quality of Life (HRQOL) in Patients With Chronic Obstructive Pulmonary Disease using the COPD Assessment Test (CAT).
    Akor AA; Bamidele A; Erhabor GE
    West Afr J Med; 2020; 37(3):275-280. PubMed ID: 32476122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of swallowing dysfunction screened in Swedish cohort of COPD patients.
    Gonzalez Lindh M; Blom Johansson M; Jennische M; Koyi H
    Int J Chron Obstruct Pulmon Dis; 2017; 12():331-337. PubMed ID: 28176891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GOLD Classification of COPD: Discordance in Criteria for Symptoms and Exacerbation Risk Assessment.
    Mittal R; Chhabra SK
    COPD; 2017 Feb; 14(1):1-6. PubMed ID: 27723367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association of patient-reported symptoms and clinical and lung function parameters in patients with chronic obstructive pulmonary disease in stable phase.
    Vulpi MR; Liotino V; Dragonieri S; Buonamico E; Dimitri M; Capozzolo A; Resta E; Lozupone M; Panza F; Resta O
    Expert Rev Respir Med; 2020 Jun; 14(6):637-643. PubMed ID: 32249627
    [No Abstract]   [Full Text] [Related]  

  • 7. Symptoms and quality of life in patients with chronic obstructive pulmonary disease treated with aclidinium in a real-life setting.
    Lange P; Godtfredsen NS; Olejnicka B; Paradis BA; Curiac D; Humerfelt S; Telg G; Christensen HN; Bitsch MA; Andersen EW; Bjermer L
    Eur Clin Respir J; 2016; 3():31232. PubMed ID: 27387608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between steps of 6MWT and COPD severity: a cross-sectional study.
    Zeng GS; Chen LC; Fan HZ; Wu LL; Wu XP; Fang ZK; He X; Yu HP
    Int J Chron Obstruct Pulmon Dis; 2019; 14():141-148. PubMed ID: 30643400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic obstructive pulmonary disease (COPD) assessment test scores corresponding to modified Medical Research Council grades among COPD patients.
    Lee CH; Lee J; Park YS; Lee SM; Yim JJ; Kim YW; Han SK; Yoo CG
    Korean J Intern Med; 2015 Sep; 30(5):629-37. PubMed ID: 26354057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discrepancies between modified Medical Research Council dyspnea score and COPD assessment test score in patients with COPD.
    Rhee CK; Kim JW; Hwang YI; Lee JH; Jung KS; Lee MG; Yoo KH; Lee SH; Shin KC; Yoon HK
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1623-31. PubMed ID: 26316736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison between COPD Assessment Test (CAT) and modified Medical Research Council (mMRC) dyspnea scores for evaluation of clinical symptoms, comorbidities and medical resources utilization in COPD patients.
    Cheng SL; Lin CH; Wang CC; Chan MC; Hsu JY; Hang LW; Perng DW; Yu CJ; Wang HC;
    J Formos Med Assoc; 2019 Jan; 118(1 Pt 3):429-435. PubMed ID: 30150099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of Clinical COPD Questionnaire in Patients with COPD: A Cross-Sectional Observational Study.
    Zhou Z; Zhou A; Peng Y; Duan J; Zeng Y; Zhao Y; Cheng W; Chen P
    Respiration; 2020; 99(7):606-616. PubMed ID: 32659763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Respiratory Symptoms Items from the COPD Assessment Test Identify Ever-Smokers with Preserved Lung Function at Higher Risk for Poor Respiratory Outcomes. An Analysis of the Subpopulations and Intermediate Outcome Measures in COPD Study Cohort.
    Martinez CH; Murray S; Barr RG; Bleecker E; Bowler RP; Christenson SA; Comellas AP; Cooper CB; Couper D; Criner GJ; Curtis JL; Dransfield MT; Hansel NN; Hoffman EA; Kanner RE; Kleerup E; Krishnan JA; Lazarus SC; Leidy NK; O'Neal W; Martinez FJ; Paine R; Rennard SI; Tashkin DP; Woodruff PG; Han MK;
    Ann Am Thorac Soc; 2017 May; 14(5):636-642. PubMed ID: 28459622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modified Medical Research Council scale vs Baseline Dyspnea Index to evaluate dyspnea in chronic obstructive pulmonary disease.
    Perez T; Burgel PR; Paillasseur JL; Caillaud D; Deslée G; Chanez P; Roche N;
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1663-72. PubMed ID: 26316740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of the new GOLD COPD staging system to a US primary care cohort, with comparison to physician and patient impressions of severity.
    Mapel DW; Dalal AA; Johnson PT; Becker LK; Hunter AG
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1477-86. PubMed ID: 26251587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A self-management approach using self-initiated action plans for symptoms with ongoing nurse support in patients with Chronic Obstructive Pulmonary Disease (COPD) and comorbidities: the COPE-III study protocol.
    Lenferink A; Frith P; van der Valk P; Buckman J; Sladek R; Cafarella P; van der Palen J; Effing T
    Contemp Clin Trials; 2013 Sep; 36(1):81-9. PubMed ID: 23770110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of symptom burden and adherence to respiratory medications in individuals self-reporting a diagnosis of COPD within a community pharmacy setting.
    Bollmeier SG; Seaton TL; Prosser TR; Chou YT; Reckenberg K; Hahn B; Stanford RH; Ray R
    J Am Pharm Assoc (2003); 2019; 59(4):479-488.e1. PubMed ID: 31126830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and Perception of 24-Hour Symptom Patterns in Patients With Stable Chronic Obstructive Pulmonary Disease in Spain.
    Soler-Cataluña JJ; Sauleda J; Valdés L; Marín P; Agüero R; Pérez M; Miravitlles M
    Arch Bronconeumol; 2016 Jun; 52(6):308-15. PubMed ID: 26774700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological treatment response according to the severity of symptoms in patients with chronic obstructive pulmonary disease.
    Lee JS; Seo JB; Lee SM; Park TS; Lee SW; Oh YM; Lee JH; Kim EK; Kim TH; Park JH; Sheen SS; Lim SY; Jung I; Lee SD
    J Thorac Dis; 2015 Oct; 7(10):1765-73. PubMed ID: 26623099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of chronic nasal symptoms with dyspnoea and quality-of-life impairment in chronic obstructive pulmonary disease.
    Caillaud D; Chanez P; Escamilla R; Burgel PR; Court-Fortune I; Nesme-Meyer P; Deslee G; Perez T; Pinet C; Roche N;
    Respirology; 2014 Apr; 19(3):346-52. PubMed ID: 24330257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.